Paul Komminoth

16.0k total citations · 2 hit papers
182 papers, 10.5k citations indexed

About

Paul Komminoth is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Paul Komminoth has authored 182 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 59 papers in Molecular Biology and 57 papers in Oncology. Recurrent topics in Paul Komminoth's work include Neuroendocrine Tumor Research Advances (64 papers), Neuroblastoma Research and Treatments (35 papers) and Lung Cancer Research Studies (29 papers). Paul Komminoth is often cited by papers focused on Neuroendocrine Tumor Research Advances (64 papers), Neuroblastoma Research and Treatments (35 papers) and Lung Cancer Research Studies (29 papers). Paul Komminoth collaborates with scholars based in Switzerland, Germany and United States. Paul Komminoth's co-authors include Aurel Perren, Philipp U. Heitz, Parvin Saremaslani, Ernst‐Jan M. Speel, Jürgen Roth, Günter Klöppel, Guido Rindi, Anne Couvelard, Bertram Wiedenmann and Wouter W. de Herder and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Paul Komminoth

180 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

2006 1.2k citations Guido Rindi, Anne Couvelard et al. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin profile →
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

2007 693 citations Guido Rindi, Günter Klöppel et al. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Komminoth Switzerland	58	5.5k	5.4k	3.4k	2.7k	1.8k	182	10.5k
Philipp U. Heitz Switzerland	56	4.7k 0.8×	4.4k 0.8×	2.7k 0.8×	2.2k 0.8×	2.4k 1.4×	153	9.2k
Ernst‐Jan M. Speel Netherlands	49	3.1k 0.6×	3.9k 0.7×	1.2k 0.3×	2.0k 0.8×	1.8k 1.0×	210	8.0k
Victor E. Gould United States	53	2.3k 0.4×	3.2k 0.6×	1.6k 0.5×	1.8k 0.7×	1.3k 0.7×	189	7.9k
Toru Kameya Japan	41	2.0k 0.4×	2.7k 0.5×	1.2k 0.3×	1.9k 0.7×	1.2k 0.7×	226	6.6k
Alain Calender France	39	2.3k 0.4×	2.1k 0.4×	1.4k 0.4×	837 0.3×	850 0.5×	133	7.2k
Jiří Bártek Denmark	41	897 0.2×	2.0k 0.4×	1.4k 0.4×	2.2k 0.8×	957 0.5×	168	6.4k
Fausto J. Rodríguez United States	47	1.5k 0.3×	810 0.1×	2.2k 0.6×	2.3k 0.9×	717 0.4×	214	7.5k
Maurilio Ponzoni Italy	65	1.1k 0.2×	6.6k 1.2×	3.1k 0.9×	4.7k 1.7×	1.3k 0.8×	296	16.6k
Peter G. Isaacson United Kingdom	53	1.3k 0.2×	4.9k 0.9×	1.2k 0.4×	1.3k 0.5×	2.8k 1.5×	132	12.8k
Hector Battifora United States	58	640 0.1×	4.2k 0.8×	1.1k 0.3×	2.9k 1.1×	1.6k 0.9×	160	10.6k

Countries citing papers authored by Paul Komminoth

Since Specialization

Citations

This map shows the geographic impact of Paul Komminoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Komminoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Komminoth more than expected).

Fields of papers citing papers by Paul Komminoth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Komminoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Komminoth. The network helps show where Paul Komminoth may publish in the future.

Co-authorship network of co-authors of Paul Komminoth

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Komminoth. A scholar is included among the top collaborators of Paul Komminoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Komminoth. Paul Komminoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zulewski, Henryk, Luca Giovanella, Stefan Bilz, et al.. (2019). Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland. Swiss Medical Weekly. 149(304). w14700–w14700. 14 indexed citations

Schneider, Stephanie, Silke Potthast, Paul Komminoth, Guido Schwegler, & Steffen Böhm. (2017). PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis. Case Reports in Oncology. 10(2). 473–478. 58 indexed citations

Dettmer, Matthias S., Aurel Perren, Holger Moch, et al.. (2014). MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights. Journal of Molecular Endocrinology. 52(2). 181–189. 75 indexed citations

Meyer, Philipp T., Annelies Schnider, Paul Komminoth, et al.. (2013). Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer. European Radiology. 23(9). 2492–2502. 30 indexed citations

Wegener, Susanne, Juliane Bremer, Paul Komminoth, Hans H. Jung, & Michael Weller. (2010). Paraneoplastic Necrotizing Myopathy with a Mild Inflammatory Component: A Case Report and Review of the Literature. Case Reports in Oncology. 3(1). 88–92. 20 indexed citations

Schmitt, Anja, Sonja Schmid, Thomas Rudolph, et al.. (2009). VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors. Endocrine Related Cancer. 16(4). 1219–1227. 80 indexed citations

Perren, Aurel, et al.. (2009). Klassifikation gastroenteropankreatischer neuroendokriner Tumoren. Der Radiologe. 49(3). 198–205. 6 indexed citations

Klöppel, Günter, Anne Couvelard, Aurel Perren, et al.. (2008). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification. Neuroendocrinology. 90(2). 162–166. 247 indexed citations

Brändle, Michael, Paul Komminoth, Parvin Saremaslani, et al.. (2004). A Novel Succinate Dehydrogenase Subunit B Gene Mutation, H132P, Causes Familial Malignant Sympathetic Extraadrenal Paragangliomas. The Journal of Clinical Endocrinology & Metabolism. 89(1). 362–367. 21 indexed citations

10.

Dannenberg, Hilde, Paul Komminoth, Winand N.M. Dinjens, Ernst‐Jan M. Speel, & Ronald R. de Krijger. (2003). Molecular Genetic Alterations in Adrenal and Extra-Adrenal Pheochromocytomas and Paragangliomas. Endocrine Pathology. 14(4). 329–350. 20 indexed citations

11.

Zhao, Jianming, Jürgen Roth, Beata Bode‐Lesniewska, et al.. (2002). Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors. Genes Chromosomes and Cancer. 34(1). 48–57. 94 indexed citations

12.

Barghorn, André, Ernst‐Jan M. Speel, Parvin Saremaslani, et al.. (2001). Putative Tumor Suppressor Loci at 6q22 and 6q23-q24 Are Involved in the Malignant Progression of Sporadic Endocrine Pancreatic Tumors. American Journal Of Pathology. 158(6). 1903–1911. 70 indexed citations

13.

Mihic‐Probst, Daniela, et al.. (2001). Spitzoid malignant melanoma with lymph-node metastasis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 439(6). 823–826. 11 indexed citations

14.

Gimm, Oliver, Aurel Perren, Deborah J. Marsh, et al.. (2000). Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid Tumors. American Journal Of Pathology. 156(5). 1693–1700. 282 indexed citations

15.

Walch, Axel, Paul Komminoth, Peter Hutzler, et al.. (2000). Microdissection of Tissue Sections: Application to the Molecular Genetic Characterisation of Premalignant Lesions. Pathobiology. 68(1). 9–17. 15 indexed citations

16.

Perren, Aurel, Alexander H. Boag, Patricia L. M. Dahia, et al.. (1999). Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast. American Journal Of Pathology. 155(4). 1253–1260. 327 indexed citations

17.

Komminoth, Paul. (1997). Multiple endokrine Neoplasie Typ 1 und 2 Diagnostische Leitlinien und molekulare Pathologie 1997. Der Pathologe. 18(4). 286–300. 1 indexed citations

18.

Seelentag, Walter, Paul Komminoth, Parvin Saremaslani, Ph. U. Heitz, & Jürgen Roth. (1996). CD44 isoform expression in the diffuse neuroendocrine system. I. Normal cells and hyperplasia. Histochemistry and Cell Biology. 106(6). 543–550. 5 indexed citations

19.

Schröder, Sören, Wolfram Jochum, H. Kastendieck, et al.. (1995). Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.. PubMed Central. 147(6). 1600–7. 28 indexed citations

20.

Komminoth, Paul, et al.. (1993). Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections. Histochemistry. 99(2). 151–162. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact